Zibb.com: Quidel Corporation (Industry News & Blogs)

Quidel Enters Oversold Territory (Zacks.com)

Tue, 17 Nov 2009 15:47:53 GMT

Quidel Corp.’s (NasdaqGS: QDEL - News) share price has entered into oversold territory with a stochastic value of 12.19. Analysts have been increasing their estimates on

Quidel (QDEL) Bearish Technical Alert - Trend Down 7.2% - Zibb.co...

Mon, 16 Nov 2009 18:53:37 GMT

Quidel (NASDAQ:QDEL) is trading 0.3% lower (down $0.04 to $13.88) today on volume of 102,538 shares. The stock has traded within a 52-week range of $7.05 and $18.81. Quidel is currently below its 50-day moving average of $15.68 and should find support at its 200-day moving average of $13.19.

Quidel Corporation Q3 Earnings Call Transcript (at Seeking Alpha)

Mon, 19 Oct 2009 20:27:09 GMT

Good day, ladies and gentlemen, and welcome to the Quidel Corporation third quarter 2009 conference call. At this time, all participants are in a listen-only mode. (Operator's Instructions) I'd now like to turn the call over to Mr. John Radak. Please go ahead, sir. John M. Radak Good morning.

Swine Flu Spurs Investor Interest in San Diego Biomedical Firms

Mon, 21 Sep 2009 12:40:38 GMT

San Diego’s Quidel, which signaled it would report better-than-expected quarterly results on Sept. 10, isn’t the only San Diego biomedical company to get a

Quidel says FDA clears QuickVue swine flu version

Thu, 17 Sep 2009 13:25:26 GMT

Quidel says regulators approve version of QuickVue flu test that can detect swine flu

Quidel "average," target price raised

Thu, 23 Jul 2009 17:37:47 GMT

NEW YORK, July 23 (newratings.com) - Analysts at Caris & Company reiterate their "average" rating on Quidel Corporation (ticker: QDEL). The target price has been raised from $11 to $13. [more]

Get Ready for the Bounce

Mon, 27 Apr 2009 15:12:01 GMT

"Don't catch a falling knife," as the old saw commands. (Pardon my mixing a cutlery metaphor.) The idea of buying a former superstar stock at a discount price certainly has its attractions, but you've got to make sure you catch the haft -- not the blade. That's where Motley Fool CAPS comes in.

Quidels QuickVue® iFOB Test Results Show High Correlation with Qu...

Tue, 09 Dec 2008 13:00:00 GMT

Quidels QuickVue® iFOB Test Results Show High Correlation with Quantitative Laboratory Assay for Fecal Occult Blood Using Stools from Patients with Post-Colonoscopy Based Clinical Diagnosis. - SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ:QDEL - News), a leading provider of rapid

Quidel Corp. F3Q08 (Qtr End 9/30/08) Earnings Call Transcript (at...

Thu, 23 Oct 2008 02:10:17 GMT

Ladies and gentlemen thank you for standing by. Welcome to the Quidel Corporation Third Quarter 2008 Conference Call. At this time, all participants are in a listen-only mode. Later, instructions will be given for the question-and-answer session. (Operator Instructions).

Quidel Corporation and Prodesse, Inc. Announce Flu and RSV Molecu...

Tue, 20 May 2008 12:00:00 GMT

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ:QDEL), a leading provider of rapid point-of-care (POC) diagnostic tests, and Prodesse, Inc., a biotechnology company focused on developing molecular diagnostic reagents for a variety of infectious diseases, announced today an agreement between

With Quidel, the focus is on the diagnosis

Mon, 24 Mar 2008 17:26:00 GMT

Filed under: Stocks to BuyThe choppy/consolidating (or perhaps worse) market conditions sometimes give the impression that growth plays do not exist, but that is not the case, and one growth company worth a review is Quidel

Quidel 4th-Quarter Profit Drops by More Than Half, Blames Late Fl...

Thu, 21 Feb 2008 23:04:00 GMT

SAN DIEGO (AP) - Quidel Corp., a maker of medical tests, said Thursday its fourth-quarter profit fell by more than half, blaming a delay in the start of the domestic flu season that pushed orders for flu tests into the next quarter.

Cramer's 'Mad Money' Recap: Spitzer Weighs In On the Credit Crisi...

Sat, 16 Feb 2008 00:41:47 GMT

The New York governor says he is taking steps to shore up the capital reserves of bond insurers.. Check out TheStreet for the latest stock market news and financial investment headlines.

Avian flu-detecting chips licensed for distribution

Fri, 05 Jan 2007 00:00:00 GMT

A microarray-based influenza detection technology verified by the Centers for Disease Control and Prevention has been licensed for worldwide distribution.

News: Quidel and BioHelix Join Forces to Develop Handheld Tests f...

BioHelix' isothermal-amplification technology and expertise in the R&D of nucleic acid technologies for diagnostic applications will be leveraged.

Pharmacy Choice - Pharmaceutical News - Quidel's Flu Test Receive...

A clinical study to validate the performance of Quidel's 10-minute diagnostic test for influenza, the QuickVue Influenza A+B test, was completed in Australia during that continent's flu season from July through September 2005.

Quidel, Church & Dwight Announce Partnership | CosmeticsAndToilet...

Quidel Corp., a leading provider of rapid point-of-care diagnostic tests, announced a partnership in the area of women's health with Church & Dwight Co. Inc.

Quidel Corporation News - The New York Times

LEAD: Monoclonal Antibodies Inc., which sells fertility-test kits, said it had reached an agreement with the privately held Quidel Corporation under which Monoclonal would exchange about 9.7 million of its common shares for all shares of Quidel.

NEWS-Line Communications - Nurse Practitioners

10-Minute QuickVue Influenza Test Helps Physicians Differentiate Between Influenza and Other Common Respiratory Illnesses Making Their Way Across the U.S.

Packaging Today - Quidel and Roche Pharma tackle flu in Germany

Rapid point-of-care (POC) company Quidel Corporation has forged an exclusive partnership to provide Switzerland-based Roche Pharma with the QuickVue Influenza A+B rapid diagnostic test along with its Tamiflu (Oseltamivir) antiviral. The move is aimed at helping to improve patient recovery time.

SAN DIEGO, Oct 08, 2008 (BUSINESS WIRE) -- Quidel Corporation (NA...

SAN DIEGO, Oct 08, 2008 (BUSINESS WIRE) -- Quidel Corporation (NASDAQ GM:QDEL) , a leading provider of rapid point-of-care (POC) diagnostic tests, will release 2008 third quarter financial results after market close on Wednesday, October 22, 2008. Following the release of the results, Caren L.

Quidel Down 4.5% Since SmarTrend's Sell Recommendation - Zibb.com

Sat, 31 Oct 2009 08:14:29 GMT

SmarTrend, our proprietary pattern recognition system, called a Downtrend for Quidel (NASDAQ:QDEL) on October 19, 2009 at $14.96. Since then, Quidel has returned 4.5% as of Friday's recent price of $14.28. Want to profit from these alerts? Go to www.mysmartrend.com now for a FREE two-week trial.

Quidel Corporation (QDEL) Corporate Event Announcement Notice - Z...

Mon, 19 Oct 2009 21:01:22 GMT

Quidel Corporation (QDEL) Expected next earnings release: Announcement date: 1/14/2010 - During Market Earnings Quarter: Q3 Announcement Status: Unconfirmed Expected next investor conference call information: Conference Call Date: 10/19/2009 Conference Call Time (ET): 10:00 AM Conference Call URL:

Quidel Corporation Q3 Earnings Call Transcript

Mon, 19 Oct 2009 20:27:09 GMT

Quidel Corporation (QDEL)Q3 2009 Earnings CallOctober 10, 2009 10:00 am ET

Quidel Announces Launch of Their MicroVue® C5a EIA Kit for Resear...

Fri, 16 Oct 2009 11:30:00 GMT

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL - News), a leading provider of rapid point-of-care diagnostic tests, today announced the